Related Experiment Video
Updated: May 12, 2026

Monitoring of Nanodrug Accumulation in Murine Breast Cancer Metastases
Published on: August 23, 2024
MicroRNAs: cobblestones on the road to cancer metastasis
Valentina Profumo1, Paolo Gandellini
1Department of Experimental Oncology and Molecular Medicine, Fondazione IRCCS Istituto Nazionale Tumori, Milano, Italy.
Abstract:
Cancer metastasis is the product of a multistep process during which tumor cells, responding to different intrinsic and extrinsic stimuli, detach from the primary tumor mass, invade the contiguous stroma, migrate over a long distance, and colonize distant organs. Despite the well-established role of protein-coding genes behind such events, emerging evidence suggests how genetic and epigenetic alterations in microRNAs equally contribute to cancer metastasis. In this review, we retrace step-to-step all the most salient phases of the tumor dissemination process, by focusing on the role that specific microRNAs play from the time a cancer cell leaves the primary tumor until it acquires the ability to form secondary tumors at distant sites. We also provide a discussion of relevant conceptual and technological issues that need to be addressed before a microRNA-based therapy might be exploited in the clinical setting for the prevention and cure of the metastatic disease.
Insights
MicroRNAs (miRNAs) significantly contribute to cancer metastasis, influencing tumor cell detachment, invasion, migration, and colonization. Further research is needed to develop miRNA-based therapies for metastatic cancer.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- Cancer metastasis is a complex, multistep process involving tumor cell detachment, invasion, migration, and colonization.
- Protein-coding genes are known drivers of metastasis, but microRNAs (miRNAs) also play a crucial role through genetic and epigenetic alterations.
Purpose of the Study:
- To review the role of specific microRNAs in each phase of cancer metastasis, from primary tumor escape to distant organ colonization.
- To discuss challenges and opportunities for developing microRNA-based therapies for metastatic disease.
Main Methods:
- Literature review focusing on the molecular mechanisms of cancer metastasis.
- Analysis of the involvement of microRNAs in tumor dissemination.
- Discussion of clinical translation hurdles for microRNA therapeutics.
Main Results:
- Specific microRNAs are implicated in regulating tumor cell detachment, stromal invasion, long-distance migration, and colonization of distant organs.
- Genetic and epigenetic alterations of miRNAs are key contributors to the metastatic cascade.
- Significant conceptual and technological challenges remain for clinical application of miRNA-based therapies.
Conclusions:
- MicroRNAs are critical regulators of cancer metastasis and represent potential therapeutic targets.
- Further investigation is required to overcome barriers to clinical implementation of miRNA-based strategies for preventing and treating metastatic cancer.
More Related Videos
09:06MicroRNA Amplification and Recognition through Locked-nucleic-acid In situ Hybridization as a Novel Detection and Quantification Method
Published on: October 7, 2025
12:13Sequencing Small Non-coding RNA from Formalin-fixed Tissues and Serum-derived Exosomes from Castration-resistant Prostate Cancer Patients
Published on: November 19, 2019
Related Concept Videos
Metastasis
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
MicroRNAs
MicroRNAs
MicroRNAs
Cancer Cell Migration through Invadopodia
Adaptive Mechanisms in Cancer Cells
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...